Mainstreaming genetic testing by oncology teams

Hunter Family Cancer Service, NSW

Margaret Gleeson is a Senior Cancer Genetic Counsellor with the Hunter Family Cancer Service in Newcastle. She has a background in Oncology Nursing and over 20 years clinical experience in cancer genetics. Margaret has been involved in many related research projects, with her most recent being the issue of treatment focused genetic testing in breast and ovarian cancer. She was part of the team leading the roll out of the Mainstreaming Implementation project and research study.

Victorian Comprehensive Cancer Centre

Maira Kentwell is a senior genetic counsellor and genetic counsellor lead for the Parkville Familial Cancer Centre. Ms Kentwell has 15 years of experience as a genetic counsellor. Her primary interests are in new models of service delivery in cancer genetic counselling, and novel approaches to ongoing training and education of genetic counsellors including a peer-based approach to supervision. Over the past 7 years, Maira has been focused on the development of mainstream genetic counselling for ovarian cancer patients for BRCA1 and BRCA2 genetic testing locally as well as nationally through the Mainstreaming Working Party and the COSA Familial Cancer Group.

Genetic Health Queensland

Dr Helen Mar Fan is a dual trained medical oncologist and clinical geneticist who works in the cancer service at Genetic Health Queensland. She had particular interests in evidence based medicine and the ongoing genetic education of non-genetic healthcare professionals.

Prince of Wales Hospital, NSW

A/Prof Kathy Tucker is a clinical translation-orientated researcher with clinical, administrative and teaching commitments. She is a senior staff specialist at Prince of Wales Hospital (POWH) and sees patients at POWH, Sydney Children's Hospital, St George Hospital as well as (via telemedicine) The Canberra Hospital and Wollongong. She was Head of the Hereditary Cancer Centre from 1994-2016. She is currently the clinical lead for the networked service. Her current passion is translating genomic medicine into the clinical space safely. She is coauthor on almost 200 peer reviewed articles.

Frankston Hospital, Royal Melbourne Hospital and Cabrini Health, VIC

Dr Yoland Antill is a Medical Oncologist in Melbourne. She started her training at Royal North Shore Hospital in Sydney before completing a fellowship and doctoral studies at the Peter MacCallum Cancer Centre and now works full time across both public and private appointments at Frankston Hospital, Royal Melbourne Hospital and Cabrini Health as a Medical Oncologist and Cancer Genetics specialist. Her working and research interests are in the management of Breast and Gynaecological cancers. Yoland is the lead investigator for a number of local and international research studies and is involved in the development and conduct of clinical trials and has published over 30 papers in International Journals. She has more than 15 years’ experience in both medical oncology and in the diagnosis and management of hereditary cancer syndromes.

Hunter Family Cancer Service, NSW

Margaret Gleeson is a Senior Cancer Genetic Counsellor with the Hunter Family Cancer Service in Newcastle. She has a background in Oncology Nursing and over 20 years clinical experience in cancer genetics. Margaret has been involved in many related research projects, with her most recent being the issue of treatment focused genetic testing in breast and ovarian cancer. She was part of the team leading the roll out of the Mainstreaming Implementation project and research study.

Victorian Comprehensive Cancer Centre

Maira Kentwell is a senior genetic counsellor and genetic counsellor lead for the Parkville Familial Cancer Centre. Ms Kentwell has 15 years of experience as a genetic counsellor. Her primary interests are in new models of service delivery in cancer genetic counselling, and novel approaches to ongoing training and education of genetic counsellors including a peer-based approach to supervision. Over the past 7 years, Maira has been focused on the development of mainstream genetic counselling for ovarian cancer patients for BRCA1 and BRCA2 genetic testing locally as well as nationally through the Mainstreaming Working Party and the COSA Familial Cancer Group.

Genetic Health Queensland

Dr Helen Mar Fan is a dual trained medical oncologist and clinical geneticist who works in the cancer service at Genetic Health Queensland. She had particular interests in evidence based medicine and the ongoing genetic education of non-genetic healthcare professionals.

Prince of Wales Hospital, NSW

A/Prof Kathy Tucker is a clinical translation-orientated researcher with clinical, administrative and teaching commitments. She is a senior staff specialist at Prince of Wales Hospital (POWH) and sees patients at POWH, Sydney Children's Hospital, St George Hospital as well as (via telemedicine) The Canberra Hospital and Wollongong. She was Head of the Hereditary Cancer Centre from 1994-2016. She is currently the clinical lead for the networked service. Her current passion is translating genomic medicine into the clinical space safely. She is coauthor on almost 200 peer reviewed articles.

Frankston Hospital, Royal Melbourne Hospital and Cabrini Health, VIC

Dr Yoland Antill is a Medical Oncologist in Melbourne. She started her training at Royal North Shore Hospital in Sydney before completing a fellowship and doctoral studies at the Peter MacCallum Cancer Centre and now works full time across both public and private appointments at Frankston Hospital, Royal Melbourne Hospital and Cabrini Health as a Medical Oncologist and Cancer Genetics specialist. Her working and research interests are in the management of Breast and Gynaecological cancers. Yoland is the lead investigator for a number of local and international research studies and is involved in the development and conduct of clinical trials and has published over 30 papers in International Journals. She has more than 15 years’ experience in both medical oncology and in the diagnosis and management of hereditary cancer syndromes.